Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance.
Saved in:
| Title: | Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance. |
|---|---|
| Authors: | Elmannan AA; Al Neelain University, Steen Street, P.O. Box 7294, Code: 11123, Khartoum, Sudan. abeeratta@gmail.com., Elmardi KA; Federal Ministry of Health, Khartoum, Sudan. khalid.elmardi@gmail.com., Idris YA; Gezira State Ministry of Health, Wad Medani, Sudan. yassir.idris@gmail.com., Spector JM; Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. spectorjm@gmail.com., Ali NA; Federal Ministry of Health, Khartoum, Sudan. nahid100@hotmail.com., Malik EM; Gezira State Ministry of Health, Wad Medani, Sudan. fatihmmalik@gmail.com. |
| Source: | BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2015 Mar 26; Vol. 16, pp. 3. Date of Electronic Publication: 2015 Mar 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511 (Electronic) Linking ISSN: 20506511 NLM ISO Abbreviation: BMC Pharmacol Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
